伪连续动脉自旋标记在缺血性卒中中的可靠性及与其他灌注技术的比较:系统综述与荟萃分析
本系统综述与荟萃分析纳入11项研究共383例缺血性卒中患者,评估伪连续动脉自旋标记(pCASL)测量的脑血流量在缺血性卒中中的重测信度,并与DSC、CTP及PET进行比较。仅1项低质量、高偏倚风险研究评估了重测信度,未发现重复绝对CBF测量随时间有显著差异且各区域信度优秀;在缺血性卒中超急性期,pCASL与DSC在梗死核心相对CBF及低灌注体积上无显著差异;未检索到PET研究。
要点
- pCASL与DSC在超急性期缺血性卒中的梗死核心相对CBF及低灌注体积上无显著差异。
- 仅1项低质量、高偏倚风险研究评估了pCASL的重测信度,重复绝对CBF测量未见显著差异。
- 纳入研究数量少,无法对主要结局进行荟萃分析,pCASL与其他灌注技术指标的可比性证据有限。
核心结论
- 无法就pCASL的重测信度或该技术与DSC、CTP或PET在缺血性卒中不同时期所获指标的可比性得出稳健结论。
研究设计与样本
- 系统综述与荟萃分析,检索MEDLINE、EMBASE和LILACS,纳入11项研究共383例缺血性卒中参与者,采用QUADAS-2和可靠性研究质量评价工具评估偏倚风险与方法学质量,使用逆方差法的随机效应荟萃分析并以I²统计量评估异质性。
诊断标准与关键数值
- 超急性期缺血性卒中,pCASL与DSC在梗死核心相对CBF上无显著差异(95% CI,-0.11至0.13;I²=0%)。
- 超急性期缺血性卒中,pCASL与DSC在低灌注体积上无显著差异(95% CI,-0.28至0.68;I²=69%)。
- 仅1项低质量、高偏倚风险研究评估重测信度,发现重复绝对CBF测量随时间无显著差异且各区域信度优秀。
临床应用与阅片要点
- 在超急性期缺血性卒中,pCASL与DSC在梗死核心相对CBF及低灌注体积上显示无显著差异,但证据限于纳入研究数量少。
- pCASL与其他DSC或CTP指标的可比性证据有限,且未检索到PET研究。
局限性
- 纳入研究数量少,妨碍了对主要结局进行荟萃分析,并限制了对次要结局的结论。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND: Pseudocontinuous arterial spin-labeling (pCASL) is a noninvasive, gadolinium-free MRI technique for assessing brain perfusion.
PURPOSE: The test-retest reliability of pCASL-derived CBF measurements in ischemic stroke (IS) were evaluated and pCASL metrics were compared with those from DSC, CTP, and PET.
DATA SOURCES: Systematic searches were conducted in MEDLINE, EMBASE, and LILACS. Risk of bias and methodologic quality were evaluated using QUADAS-2 and Quality Appraisal for Reliability Studies tools.
STUDY SELECTION: Eleven studies, encompassing 383 participants with IS were included.
DATA ANALYSIS: Random-effects meta-analysis with inverse variance method and heterogeneity assessed using I 2 statistics were used.
DATA SYNTHESIS: No PET studies were identified. Only 1 low-quality, high-risk-of-bias study assessed test-retest reliability, finding no significant differences in repeated absolute CBF measurements over time and excellent reliability across regions. Most studies comparing pCASL with DSC, and all comparing pCASL with CTP, had a low risk of bias. In the hyperacute phase of IS, pCASL and DSC showed no significant differences in infarct core relative CBF (95% CI, -0.11 to 0.13; I 2 = 0%) or hypoperfusion volumes (95% CI, -0.28 to 0.68; I 2 = 69%). Evidence on the comparability of pCASL with other DSC or CTP metrics was limited.
LIMITATIONS: The small number of included studies prevented a meta-analysis for the primary outcome and limited conclusions for secondary outcomes.
CONCLUSIONS: Robust conclusions about the test-retest reliability of pCASL or the comparability of metrics obtained with this technique and DSC, CTP, or PET in different phases after IS could not be drawn.
引用
- Kroth JB, da Guarda SNF, Wang DJJ, et al. Reliability of Pseudocontinuous Arterial Spin-Labeling in Ischemic Stroke and Comparison with Other Perfusion Techniques: Systematic Review and Meta-Analysis. AJNR Am J Neuroradiol. 2026. PMID: 41067913. doi:10.3174/ajnr.A9031
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。